1
Lioudmila Tchistiakova, Marion T Kasaian, Debra D Donaldson, Xiang Yang Tan, Davinder Gill, Macy X Jin, Bruce Jacobson, Samuel J Goldman, John Knopf, Angela M Widom: IL-13 binding agents. Wyeth, Lowrie Lando & Anastasi, March 10, 2009: US07501121 (15 worldwide citation)

Agents (e.g., antibodies and fragments thereof) that bind specifically to IL 13 and modulate the ability of IL-13 to interact with IL-13 receptors and signaling mediators are disclosed.


2

3
Lioudmila Tchistiakova, Marion T Kasaian, Debra D Donaldson, Xiang Yang Tan, Davinder Gill, Macy X Jin, Bruce Jacobson, Samuel J Goldman, John Knopf, Angela M Widom: Nucleic acids encoding IL-13 binding agents. Wyeth, May 17, 2011: US07943342 (1 worldwide citation)

Agents (e.g., antibodies and fragments thereof) that bind specifically to IL 13 and modulate the ability of IL-13 to interact with IL-13 receptors and signaling mediators are disclosed.


4
Laird Bloom, Davinder Gill, Yulia Vugmeyster, Deborah A Young, Margot O Toole, Heath M Guay, Karissa K Adkins, Amy Arlene Weaver, Sadhana Jain, Maya Arai: Methods of treatment utilizing binding proteins of the interleukin-21 receptor. Wyeth, Fitzpatrick Cella Harper & Scinto, May 15, 2012: US08178097 (1 worldwide citation)

The present invention provides binding proteins and antigen-binding fragments thereof, including human antibodies, that specifically bind to the human interleukin-21 receptor (IL-21R), and methods of using them. The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulatin ...


5

6
Ronald Black, Lars Ekman, Ivan Lieberburg, Michael Grundman, James Callaway, Keith M Gregg, Jack Steven Jacobsen, Davinder Gill, Lioudmila Tchistiakova, Angela Widom: Immunotherapy regimes dependent on ApoE status. Wyeth, JANSSEN SCIENCES IRELAND UC, Alston & Bird, May 9, 2017: US09644025

The invention provides methods of immunotherapy of Alzheimer's and similar diseases in which the regime administered to a patient depends on the ApoE genotype of the patient.


7
Laird Bloom, Davinder Gill, Yulia Vugmeyster, Deborah A Young, David Lowe, Viia Valge Archer: Interleukin-21 receptor binding proteins. Wyeth, MedImmune, Fitzpatrick Cella Harper & Scinto, April 24, 2012: US08163884

The present invention provides binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL- ...


8

9
Ronald Black, Jack Steven Jacobsen, Lioudmila Tchistiakova, Angela Widom, Davinder Gill, Lars Ekman, Ivan Lieberburg, Michael Grundman, James Callaway, Keith M Gregg, Wagner Zago, Manuel J Buttini, Gene G Kinney: Use of tau to monitor immunotherapy. JANSSEN SCIENCES IRELAND UC, Wyeth, Alston & Bird, March 1, 2016: US09272030

The invention provides methods of immunotherapy of Alzheimer's and similar diseases in which the regime administered is monitored by measuring levels of tau.


10
Davinder Gill, Manoj Kumar Chhikara, Rakesh Rana, Juned Dalal, Deepti Singh: Process of conjugation and novel synthetic oligosaccharide-protein conjugates obtained thereof. MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT, W&C IP, October 23, 2018: US10105438

The present invention relates to an improved process of conjugation to obtain synthetic oligosaccharide-protein (OS-PR) conjugates. The process of synthetic OS-PR conjugation is a rapid process providing oligosaccharide-protein conjugates which are highly immunogenic and elicit specific and homogeno ...